ANDRESSA LACERDA, ADAM NOBLE, co-founders, Noblegen
By Elaine Watson
- Last updated on
We’re still just scratching the surface when it comes to unlocking the potential of microbial fermentation to manufacture food ingredients, says Canadian bioengineering firm Noblegen, which is developing a new breed of designer oils, proteins, and nutraceuticals from an ancient single celled micro-organism called Euglena.
Using a proprietary technique called ‘facilitated expression’ that does not involve genetic engineering, Noblegen has been able to coax the micro-organism – “a protist that could also be classified as an algae” – into producing everything from cost-effective palm oil replacements, high-oleic cooking oils and the omega-3 fatty acids EPA and DHA, to complete proteins with all nine essential amino acids, says co-founder Dr Andressa Lacerda.
“We can do this at volumes and prices that will make sense to large CPG companies; this isn’t about making $9.5m in its Series A round in early 2016, is currently seeking to raise around CAD$40m in its Series B round to expand its facilities and hire more staff, she said. “We’re growing very fast.”